In Kalundborg, population under 17,000, Novo Nordisk is making huge investments to increase production of its popular diabetes and weight-loss drugs, Ozempic and Wegovy.In Kalundborg, population under 17,000, Novo Nordisk is making huge investments to increase production of its popular diabetes and weight-loss drugs, Ozempic and Wegovy. Drugs (Pharmaceuticals), Semaglutide (Drug), Labor and Jobs, Ozempic (Drug), Production, Factories and Manufacturing, Building (Construction), Novo Nordisk A/S, Denmark, Kalundborg (Denmark) Read More
How Ozempic Is Transforming a Small Danish Town
